Astellas Pharma buys Iveric Bio for $5.9 Bn
The deal marks the fifth major overseas acquisition by Astellas
Iveric Bio | 02/05/2023 | By Sudeep Soparkar | 647
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy